Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

ADDICTION ANGELS OF AMERICA, LLC

NPI: 1396148375 · COLUMBUS, OH 43229 · Addiction Medicine (Internal Medicine) Physician · NPI assigned 10/03/2014

$3.31M
Total Medicaid Paid
105,923
Total Claims
75,463
Beneficiaries
43
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialGARCIA, ROGER (PRESIDENT)
NPI Enumeration Date10/03/2014

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 8,560 $241K
2019 20,003 $430K
2020 51,471 $1.06M
2021 11,644 $749K
2022 5,997 $353K
2023 5,155 $305K
2024 3,093 $179K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 16,009 10,739 $976K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 10,728 6,532 $535K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 3,257 2,908 $440K
90833 Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) 8,766 6,745 $251K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 6,104 3,950 $247K
90832 Psychotherapy, 30 minutes with patient 3,748 2,897 $152K
80346 2,660 1,962 $57K
80361 2,684 1,950 $49K
80362 2,553 1,875 $47K
83992 2,741 2,022 $40K
90791 Psychiatric diagnostic evaluation 378 319 $34K
80348 2,943 2,109 $30K
80349 2,818 2,060 $29K
80353 2,779 2,043 $28K
80360 2,757 2,028 $28K
80355 2,749 2,029 $28K
80366 2,734 2,017 $28K
80354 2,702 1,985 $28K
80365 2,654 1,937 $27K
80324 2,636 1,927 $27K
80372 2,619 1,916 $27K
80359 2,618 1,918 $27K
80305 4,678 2,593 $26K
80373 2,443 1,854 $25K
80358 2,224 1,690 $23K
80370 2,156 1,639 $22K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 198 189 $16K
99205 Prolong outpt/office vis 160 149 $15K
80335 1,035 735 $11K
80336 1,069 895 $10K
80363 342 267 $6K
80356 461 344 $5K
80368 378 289 $4K
80345 339 264 $3K
80323 356 282 $3K
99215 Prolong outpt/office vis 28 27 $2K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 21 19 $2K
90836 31 27 $1K
80502 100 96 $1K
81025 207 188 $1K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 13 13 $536.78
80306 32 20 $431.04
36415 Collection of venous blood by venipuncture 15 15 $32.16